Showing results (311-320 of 933) with videos related to

Sort By:
Pageof 94
Eye (London, England)|January 5, 2020
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degenerationAdam H Ross, Louise Downey, Helen Devonport, et al.
Cancer|November 21, 2015
β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemiaPhilip A Thompson, Susan M O'Brien, Lianchun Xiao, et al.
Leukemia & Lymphoma|October 12, 2022
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungalsKayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell, et al.
Blood|December 3, 2025
Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemiaRoberta S Azevedo, Elias Jabbour, Hagop M Kantarjian, et al.
Cancer|April 5, 2023
Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicityMax J Gordon, Jade E Jones, Binsah George, et al.
Blood|October 23, 2024
Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV, ZAP-70, and MRDEkaterina Kim, Shih-Shih Chen, Mariela Sivina, et al.
Haematologica|March 2, 2011
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
Blood|April 12, 2008
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapyElias Jabbour, Hagop Kantarjian, Dan Jones, et al.
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
Cancer|May 13, 2004
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemiaYupo Ma, Adnan Mansour, B Nebiyou Bekele, et al.
Pageof 94